nodes	percent_of_prediction	percent_of_DWPC	metapath
Dacarbazine—pancreatic cancer—adrenal gland cancer	0.97	1	CtDrD
Dacarbazine—POLA2—gonad—adrenal gland cancer	0.00356	0.198	CbGeAlD
Dacarbazine—POLA2—adrenal gland—adrenal gland cancer	0.0031	0.173	CbGeAlD
Dacarbazine—CYP1A2—urine—adrenal gland cancer	0.00247	0.137	CbGeAlD
Dacarbazine—CYP2E1—urine—adrenal gland cancer	0.00222	0.124	CbGeAlD
Dacarbazine—POLA2—Inhibition of replication initiation of damaged DNA by RB1/E2F1—RB1—adrenal gland cancer	0.00164	0.133	CbGpPWpGaD
Dacarbazine—PGD—adrenal cortex—adrenal gland cancer	0.00135	0.0753	CbGeAlD
Dacarbazine—PGD—gonad—adrenal gland cancer	0.00112	0.0624	CbGeAlD
Dacarbazine—PGD—cardiac atrium—adrenal gland cancer	0.00112	0.0623	CbGeAlD
Dacarbazine—PGD—pituitary gland—adrenal gland cancer	0.00109	0.0609	CbGeAlD
Dacarbazine—POLA2—Extension of Telomeres—TERT—adrenal gland cancer	0.00104	0.0841	CbGpPWpGaD
Dacarbazine—PGD—adrenal gland—adrenal gland cancer	0.000978	0.0544	CbGeAlD
Dacarbazine—POLA2—E2F mediated regulation of DNA replication—RB1—adrenal gland cancer	0.000732	0.0591	CbGpPWpGaD
Dacarbazine—CYP1A1—cardiac atrium—adrenal gland cancer	0.000534	0.0297	CbGeAlD
Dacarbazine—POLA2—Mitotic G1-G1/S phases—TOP2A—adrenal gland cancer	0.000509	0.041	CbGpPWpGaD
Dacarbazine—POLA2—Telomere Maintenance—TERT—adrenal gland cancer	0.000473	0.0381	CbGpPWpGaD
Dacarbazine—CYP2E1—adrenal gland—adrenal gland cancer	0.000425	0.0236	CbGeAlD
Dacarbazine—POLA2—G1 to S cell cycle control—RB1—adrenal gland cancer	0.000411	0.0331	CbGpPWpGaD
Dacarbazine—POLA2—Chromosome Maintenance—TERT—adrenal gland cancer	0.000394	0.0318	CbGpPWpGaD
Dacarbazine—POLA2—G1 to S cell cycle control—CDKN2A—adrenal gland cancer	0.000361	0.0291	CbGpPWpGaD
Dacarbazine—POLA2—Synthesis of DNA—RB1—adrenal gland cancer	0.000312	0.0251	CbGpPWpGaD
Dacarbazine—POLA2—DNA Replication—RB1—adrenal gland cancer	0.000292	0.0236	CbGpPWpGaD
Dacarbazine—POLA2—G1/S Transition—RB1—adrenal gland cancer	0.000282	0.0227	CbGpPWpGaD
Dacarbazine—POLA2—S Phase—RB1—adrenal gland cancer	0.000256	0.0206	CbGpPWpGaD
Dacarbazine—POLA2—Mitotic G1-G1/S phases—RB1—adrenal gland cancer	0.000237	0.0191	CbGpPWpGaD
Dacarbazine—PGD—Carbohydrate metabolism—PRKACA—adrenal gland cancer	0.000229	0.0184	CbGpPWpGaD
Dacarbazine—POLA2—Mitotic G1-G1/S phases—CDKN2A—adrenal gland cancer	0.000209	0.0168	CbGpPWpGaD
Dacarbazine—POLA2—G1 to S cell cycle control—TP53—adrenal gland cancer	0.000201	0.0162	CbGpPWpGaD
Dacarbazine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000194	0.0156	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle, Mitotic—TOP2A—adrenal gland cancer	0.000187	0.0151	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle—TOP2A—adrenal gland cancer	0.000167	0.0135	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	0.000164	0.0133	CbGpPWpGaD
Dacarbazine—PGD—Disease—SH3KBP1—adrenal gland cancer	0.000157	0.0127	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—SDHB—adrenal gland cancer	0.000155	0.0125	CbGpPWpGaD
Dacarbazine—PGD—Disease—ZNRF3—adrenal gland cancer	0.000148	0.0119	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle—PRKACA—adrenal gland cancer	0.000147	0.0118	CbGpPWpGaD
Dacarbazine—CYP1A1—PPARA activates gene expression—MED12—adrenal gland cancer	0.000123	0.00991	CbGpPWpGaD
Dacarbazine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—adrenal gland cancer	0.00012	0.0097	CbGpPWpGaD
Dacarbazine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000116	0.00938	CbGpPWpGaD
Dacarbazine—POLA2—Mitotic M-M/G1 phases—RB1—adrenal gland cancer	0.000116	0.00938	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle—TERT—adrenal gland cancer	0.0001	0.00806	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—SDHD—adrenal gland cancer	9.98e-05	0.00805	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—RRM1—adrenal gland cancer	9.98e-05	0.00805	CbGpPWpGaD
Dacarbazine—CYP1A1—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	9.54e-05	0.00769	CbGpPWpGaD
Dacarbazine—PGD—Disease—SPRY2—adrenal gland cancer	9.27e-05	0.00747	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle, Mitotic—RB1—adrenal gland cancer	8.7e-05	0.00702	CbGpPWpGaD
Dacarbazine—PGD—Disease—MEN1—adrenal gland cancer	8.49e-05	0.00685	CbGpPWpGaD
Dacarbazine—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	8.43e-05	0.0068	CbGpPWpGaD
Dacarbazine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—adrenal gland cancer	8.29e-05	0.00669	CbGpPWpGaD
Dacarbazine—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	7.95e-05	0.00641	CbGpPWpGaD
Dacarbazine—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	7.84e-05	0.00632	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle—RB1—adrenal gland cancer	7.78e-05	0.00627	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	7.65e-05	0.00617	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—MED12—adrenal gland cancer	7.44e-05	0.006	CbGpPWpGaD
Dacarbazine—CYP1A1—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	7.34e-05	0.00592	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle—CDKN2A—adrenal gland cancer	6.84e-05	0.00552	CbGpPWpGaD
Dacarbazine—CYP2E1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	6.83e-05	0.00551	CbGpPWpGaD
Dacarbazine—PGD—Disease—PRKACA—adrenal gland cancer	6.48e-05	0.00523	CbGpPWpGaD
Dacarbazine—CYP1A1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	6.44e-05	0.0052	CbGpPWpGaD
Dacarbazine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	6.08e-05	0.00491	CbGpPWpGaD
Dacarbazine—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	5.56e-05	0.00448	CbGpPWpGaD
Dacarbazine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	5.56e-05	0.00448	CbGpPWpGaD
Dacarbazine—PGD—Disease—CDC42—adrenal gland cancer	5.5e-05	0.00443	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—PRKACA—adrenal gland cancer	5.43e-05	0.00438	CbGpPWpGaD
Dacarbazine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	5.07e-05	0.00409	CbGpPWpGaD
Dacarbazine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	5e-05	0.00403	CbGpPWpGaD
Dacarbazine—CYP1A2—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	4.68e-05	0.00377	CbGpPWpGaD
Dacarbazine—PGD—Disease—TERT—adrenal gland cancer	4.41e-05	0.00356	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—GNAS—adrenal gland cancer	4.4e-05	0.00355	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—ABCB1—adrenal gland cancer	4.32e-05	0.00348	CbGpPWpGaD
Dacarbazine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	4.11e-05	0.00331	CbGpPWpGaD
Dacarbazine—PGD—Disease—BAD—adrenal gland cancer	3.84e-05	0.00309	CbGpPWpGaD
Dacarbazine—POLA2—Cell Cycle—TP53—adrenal gland cancer	3.81e-05	0.00307	CbGpPWpGaD
Dacarbazine—CYP2E1—Biological oxidations—POMC—adrenal gland cancer	3.63e-05	0.00293	CbGpPWpGaD
Dacarbazine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	3.54e-05	0.00286	CbGpPWpGaD
Dacarbazine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	3.54e-05	0.00286	CbGpPWpGaD
Dacarbazine—PGD—Disease—BRAF—adrenal gland cancer	3.49e-05	0.00282	CbGpPWpGaD
Dacarbazine—CYP1A1—Biological oxidations—POMC—adrenal gland cancer	3.42e-05	0.00276	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	3.3e-05	0.00266	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—SDHB—adrenal gland cancer	3.25e-05	0.00262	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—SDHB—adrenal gland cancer	3.06e-05	0.00247	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—POMC—adrenal gland cancer	2.96e-05	0.00239	CbGpPWpGaD
Dacarbazine—PGD—Disease—PTGS2—adrenal gland cancer	2.82e-05	0.00228	CbGpPWpGaD
Dacarbazine—PGD—Disease—CTNNB1—adrenal gland cancer	2.52e-05	0.00204	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.41e-05	0.00194	CbGpPWpGaD
Dacarbazine—PGD—Metabolism—PTGS2—adrenal gland cancer	2.36e-05	0.00191	CbGpPWpGaD
Dacarbazine—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	2.18e-05	0.00176	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	2.11e-05	0.0017	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—RRM1—adrenal gland cancer	2.09e-05	0.00169	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—SDHD—adrenal gland cancer	2.09e-05	0.00169	CbGpPWpGaD
Dacarbazine—PGD—Disease—EGFR—adrenal gland cancer	2e-05	0.00161	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—SDHD—adrenal gland cancer	1.97e-05	0.00159	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—RRM1—adrenal gland cancer	1.97e-05	0.00159	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—SDHB—adrenal gland cancer	1.95e-05	0.00157	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—MED12—adrenal gland cancer	1.56e-05	0.00126	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	1.54e-05	0.00124	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—MED12—adrenal gland cancer	1.47e-05	0.00119	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.31e-05	0.00106	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—RRM1—adrenal gland cancer	1.26e-05	0.00101	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—SDHD—adrenal gland cancer	1.26e-05	0.00101	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—PRKACA—adrenal gland cancer	1.14e-05	0.000917	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—PRKACA—adrenal gland cancer	1.07e-05	0.000865	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.05e-05	0.000845	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—MED12—adrenal gland cancer	9.38e-06	0.000756	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—GNAS—adrenal gland cancer	9.22e-06	0.000744	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—ABCB1—adrenal gland cancer	9.05e-06	0.00073	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—GNAS—adrenal gland cancer	8.69e-06	0.000701	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—ABCB1—adrenal gland cancer	8.53e-06	0.000688	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	8.38e-06	0.000676	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	6.84e-06	0.000552	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	6.68e-06	0.000539	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—POMC—adrenal gland cancer	6.21e-06	0.000501	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—POMC—adrenal gland cancer	5.85e-06	0.000472	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—GNAS—adrenal gland cancer	5.54e-06	0.000447	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	5.44e-06	0.000439	CbGpPWpGaD
Dacarbazine—CYP2E1—Metabolism—PTGS2—adrenal gland cancer	4.95e-06	0.000399	CbGpPWpGaD
Dacarbazine—CYP1A1—Metabolism—PTGS2—adrenal gland cancer	4.67e-06	0.000377	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—POMC—adrenal gland cancer	3.73e-06	0.000301	CbGpPWpGaD
Dacarbazine—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	2.98e-06	0.00024	CbGpPWpGaD
